Cyclerion Therapeutics (CYCN) Stock Chart & Stock Price History → Biden replacement revealed? (From Paradigm Press) (Ad) Free CYCN Stock Alerts $2.77 -0.28 (-9.18%) (As of 09:38 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cyclerion Therapeutics Stock Price Performance5 Day Performance-12.86%1 Month Performance0.00%3 Month Performance-11.59%6 Month Performance-2.56%Year-To-Date Performance-8.96%1 Year Performance-47.34% Receive CYCN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… CYCN Stock Chart for Wednesday, April, 24, 2024 CYCN Chart by TradingView Cyclerion Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$2.97$2.77-6.73%$2.98$2.77132 shs$7.51 million04/22/2024$3.50$2.97-15.14%$3.46$2.913,541 shs$8.05 million04/19/2024$3.22$3.50+8.76%$3.50$3.153,292 shs$9.49 million04/18/2024$3.25$3.22-0.98%$3.22$3.22175 shs$8.72 million04/17/2024$3.15$3.25+3.17%$3.45$3.25443 shs$8.81 million04/16/2024$3.44$3.15-8.43%$3.45$3.15527 shs$8.54 million Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$3.37$3.44+2.08%$3.50$3.322,358 shs$9.32 million04/12/2024$3.05$3.45+13.11%$3.55$2.9814,231 shs$9.35 million04/11/2024$3.10$3.05-1.61%$3.11$2.804,140 shs$8.27 million04/10/2024$3.01$3.10+2.99%$3.10$2.802,311 shs$8.40 million04/09/2024$3.04$3.01-0.99%$3.30$3.0122,233 shs$8.16 million04/08/2024$3.30$3.04-7.88%$3.20$2.911,399 shs$8.24 million04/05/2024$3.19$3.30+3.61%$3.30$3.30504 shs$8.94 million04/04/2024$3.16$3.19+0.79%$3.88$3.162,904 shs$8.63 million04/03/2024$3.16$3.16$3.16$3.16236 shs$8.56 million04/02/2024$3.12$3.16+1.28%$3.16$3.061,749 shs$8.56 million04/01/2024$3.20$3.12-2.50%$3.32$3.071,432 shs$8.46 million03/29/2024$3.20$3.20$3.45$3.2018,646 shs$8.67 million03/28/2024$3.17$3.20+0.95%$3.45$3.2018,636 shs$8.67 million03/27/2024$3.10$3.17+2.26%$3.17$2.90993 shs$8.59 million03/26/2024$3.03$3.10+2.31%$3.10$3.08617 shs$8.40 million03/25/2024$3.05$3.03-0.66%$3.03$3.03312 shs$8.21 million03/22/2024$3.20$3.23+0.94%$3.27$3.05474 shs$8.75 million03/21/2024$3.15$3.20+1.59%$3.25$3.031,564 shs$8.67 million03/20/2024$3.10$3.15+1.61%$3.30$2.921,312 shs$8.54 million03/19/2024$3.20$3.10-3.13%$3.22$3.03502 shs$8.40 million03/18/2024$3.25$3.20-1.54%$3.20$2.884,070 shs$8.67 million03/15/2024$3.11$3.25+4.50%$3.36$3.10972 shs$8.81 million03/14/2024$3.01$3.11+3.32%$3.38$2.951,409 shs$8.43 million03/13/2024$3.20$3.01-5.93%$3.09$3.01893 shs$8.16 million03/12/2024$3.13$3.20+2.24%$3.20$2.801,663 shs$8.67 million03/11/2024$3.13$3.130.00%$3.37$3.10770 shs$8.48 million03/08/2024$3.10$3.13+0.97%$3.41$3.041,910 shs$8.48 million03/07/2024$2.80$3.10+10.71%$3.15$2.901,872 shs$7.60 million03/06/2024$2.90$2.80-3.39%$2.89$2.702,625 shs$6.86 million03/05/2024$3.20$2.90-9.43%$3.00$2.901,785 shs$7.10 million03/04/2024$3.17$3.20+1.11%$3.44$3.071,560 shs$7.84 million03/01/2024$3.00$3.17+5.50%$3.17$3.012,030 shs$7.75 million02/29/2024$3.11$3.00-3.54%$3.10$3.001,538 shs$7.35 million02/28/2024$2.93$3.11+6.14%$3.18$2.994,881 shs$7.62 millionThe system that called 2023’s top 7 stocks is at it again… (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here!02/27/2024$2.90$2.93+1.03%$2.99$2.904,561 shs$7.16 million02/26/2024$2.92$2.90-0.51%$3.41$2.717,742 shs$7.11 million02/23/2024$3.15$2.92-7.46%$3.70$2.864,036 shs$7.14 million02/22/2024$2.85$3.15+10.53%$3.54$2.867,169 shs$7.72 million02/21/2024$2.80$2.85+1.79%$2.91$2.851,934 shs$6.98 million02/20/2024$2.90$2.80-3.45%$2.86$2.801,670 shs$6.86 million02/19/2024$2.90$2.90+0.03%$2.90$2.90600 shs$7.11 million02/16/2024$2.86$2.86$2.90$2.81645 shs$7.01 million02/15/2024$3.05$2.86-6.23%$2.88$2.86573 shs$7.01 million02/14/2024$3.14$3.05-2.87%$3.28$2.881,470 shs$7.47 million02/13/2024$3.60$3.14-12.78%$3.46$3.122,033 shs$7.69 million02/12/2024$3.66$3.60-1.64%$3.63$3.60307 shs$8.80 million02/09/2024$3.94$3.66-7.11%$4.00$3.563,303 shs$8.97 million02/08/2024$2.80$3.94+40.71%$3.94$2.789,997 shs$9.65 million02/07/2024$2.80$2.80$2.80$2.731,026 shs$6.86 million02/06/2024$2.82$2.80-0.71%$2.80$2.64759 shs$6.86 million02/05/2024$2.79$2.82+0.91%$2.98$2.795,211 shs$6.91 million02/02/2024$2.94$2.79-4.95%$3.00$2.783,242 shs$6.85 million02/01/2024$3.00$2.94-2.00%$2.94$2.86962 shs$7.20 million01/31/2024$2.78$3.00+7.91%$3.00$2.801,497 shs$7.35 million01/30/2024$2.90$2.78-4.14%$2.87$2.732,169 shs$6.81 million01/29/2024$2.93$2.90-1.02%$2.93$2.791,220 shs$7.09 million01/26/2024$2.97$2.93-1.35%$3.02$2.541,437 shs$7.18 million01/25/2024$3.45$2.97-13.91%$3.26$2.975,115 shs$7.28 million01/24/2024$3.45$3.45$3.52$3.341,389 shs$8.45 million01/23/2024$3.45$3.45$3.55$3.451,150 shs$8.45 million Related Companies: VIRI Stock Chart TFFP Stock Chart HEPA Stock Chart LGVN Stock Chart MTEM Stock Chart ASLN Stock Chart ADIL Stock Chart CLVR Stock Chart OBSV Stock Chart AKTX Stock Chart Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.